-
The randomized, controlled trial (RCT) is believed to provide the strongest evidence for verifying both effectiveness and ineffectiveness of a given treatment. Once the RCT judges the proposed treatment as ineffective, it is rare that the treatment is ever evaluated again.
-
Good ED/ICU networks are becoming more important as more rural hospitals close due to lack of funding, says Janet Williams, MD, FACEP, director of the Center for Rural Emergency Medicine and Professor of Emergency Medicine at West Virginia University in Morgantown.
-
Advancing technology continues to reshape the way care management is practiced in the ICU and elsewhere, but early experience shows that technology is no guarantee for physician buy-in at the front end, much less patient compliance at the back end.
-
-
In patients with pulmonary embolism, elevated plasma levels of cardiac troponins help to identify a subgroup of patients who are at high risk and who may benefit from more aggressive treatment.
-
Many ICU physicians dont get the reimbursement they deserve because they quit billing for critical care too soon, says consultant Frank Lucas, who has performed chart audits based on payer mix and midnight census of 100-150 records to assess potential revenues for more than 35 ICUs.
-
The initial 80% savings rate that Denvers Centura-St. Anthony Central Hospital realized through standardizing a formulary for ICU sedative drugs has held firm for more than four years, according to medical director Joseph Heit, MD.
-
-
This study of blood culture draw sites in febrile ICU patients found that it is safe and reliable to obtain at least 1 of the blood cultures from a central venous catheter, irrespective of the type of catheter in place.
-
In 1936 Selye noted that rats exposed to stressors had enlarged adrenal glands. In the late 1940s, Kendall and Reichstein isolated cortisone as the active principle of the adrenal glands. In more recent years our understanding of the hypothalamic-pituitary-axis has grown immensely.
